© 2022 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Chief Science Policy Officer, GHLF, Senior Health Policy Fellow, PPI and Visiting Health Policy Fellow, Pioneer Institute
April 25, 2022
Article
Biosimilars provide significant savings and encourages competition in the biopharmaceutical marketplace but the United States needs to do more to empower uptake and address adoption barriers, according to Robert Popovian PharmD, MS.